Efficacy of Dexmedetomidine Versus Morphine as an Adjunct to Bupivacaine in Caudal Anesthesia.

December 18, 2020 updated by: Ahmed Abdelaziz Ismail, Cairo University

Efficacy of Dexmedetomidine Versus Morphine as an Adjunct to Bupivacaine in Caudal Anesthesia for Pediatric Thoracic Surgeries. A Randomized Controlled Trial.

The aim of this study is to compare the duration of postoperative analgesia, and any side effects of caudal dexmedetomidine versus morphine in combination with bupivacaine in pediatric patients undergoing thoracic surgeries.

Study Overview

Status

Completed

Conditions

Detailed Description

The patients will be randomized in a blinded fashion to get enrolled into 2 equal groups: Group A patients (n =25) will receive caudal epidural analgesia using dexmedetomidine with bupivacaine, whereas Group B patients (n = 25) will receive caudal epidural analgesia using morphine with bupivacaine.

Randomization will be achieved by using an online random number generator. Patient codes will be placed into sequentially numbered sealed opaque envelopes by a research assistant who is not involved in the study. An anesthesia resident not involved in patient management will be responsible for opening the envelope. The anesthesia resident will prepare the study drug according to the instructions contained within each envelope and give it to the anesthesiologist.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11562
        • Cairo University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 6 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA I, II, III.
  • Patients undergoing lung cyst excision.
  • Patients undergoing Patent Ductus Arteriosus ligation.

Exclusion Criteria:

  • Preoperative mechanical ventilation.
  • Preoperative inotropic support
  • History of mental retardation or delayed development that may interfere with pain intensity assessment
  • Known or suspected coagulopathy,
  • Any congenital anomalies of the sacrum or any infection at the site of injection.
  • Known or suspected allergy to any of the studied drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Dexmedetomidine group
A group which will receive dexamedetomidine as an adjunct to bupivacaine used in caudal anesthesia.
Caudal block with Dexametomedine as an adjuvant to bupivacaine.
Other Names:
  • Precedex
EXPERIMENTAL: Morphine group
A group which will receive morphine as an adjunct to bupivacaine used in caudal anesthesia.
Addition of morphine as adjuvant to bupivacaine during caudal block.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of postoperative analgesia in hours.
Time Frame: 3 months
Duration of postoperative analgesia in hours.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption in the first 24 hours post- operative.
Time Frame: 3 months
Opioid consumption in the first 24 hours post- operative.
3 months
The duration of ICU stay in days
Time Frame: 3 months
The duration of ICU stay in days
3 months
Pain score FLACC from 0 to 6
Time Frame: 3 months
Pain score FLACC from 0 to 6
3 months
Post operative heart rate
Time Frame: 3 months
Postoperative heart rate in beat per minute
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 28, 2020

Primary Completion (ACTUAL)

December 1, 2020

Study Completion (ACTUAL)

December 10, 2020

Study Registration Dates

First Submitted

June 21, 2020

First Submitted That Met QC Criteria

June 23, 2020

First Posted (ACTUAL)

June 24, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 22, 2020

Last Update Submitted That Met QC Criteria

December 18, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The patients data are confidential

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, Local

Clinical Trials on Dexmedetomidine

Subscribe